PE Conjugated CD19 Recombinant Rabbit Monoclonal Antibody [PSH13-44]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within human CD19 aa 1-291.
Species Reactivity
Human
Validated Applications
FC
Target Molecular Weight
Predicted band size: 61 kDa
Positive Control
Human peripheral blood cells.
Conjugation
PE
Clone Number
PSH13-44
Reactivity Data
Tested Verified (internally validated)
Published Reported in literature (not internally validated)
Predicted Predicted reactive (based on sequence homology)
Not recommended Not recommended (failed internal validation)
FC
Human
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Lot Concentration Lookup
Storage Instructions
Store at 2-8℃. Avoid freeze.
Storage Buffer
1*PBS (pH7.4), 1% BSA, 0.2% Proclean 950.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
FC
5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Target
Function
B-lymphocyte antigen CD19, also known as CD19 molecule (Cluster of Differentiation 19), B-Lymphocyte Surface Antigen B4, T-Cell Surface Antigen Leu-12 and CVID3 is a transmembrane protein that in humans is encoded by the gene CD19. In humans, CD19 is expressed in all B lineage cells. Contrary to some early doubts, human plasma cells do express CD19. CD19 plays two major roles in human B cells: on the one hand, it acts as an adaptor protein to recruit cytoplasmic signaling proteins to the membrane; on the other, it works within the CD19/CD21 complex to decrease the threshold for B cell receptor signaling pathways. Due to its presence on all B cells, it is a biomarker for B lymphocyte development, lymphoma diagnosis and can be utilized as a target for leukemia immunotherapies.
Background References
1. Pecher AC et al. CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome. JAMA. 2023 Jun
2. Fischbach F et al. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med. 2024 Jun
Flow cytometric analysis of human peripheral blood cells labelling CD19 (HA723763F, PE) and CD3 (HA600116F, FITC).
Cells were washed twice with cold PBS and resuspend. Then incubated for 1 hour at +4℃ with CD19 (HA723763F, PE, 1/1,000) compared with Rabbit IgG Isotype Control (PE, 1/1,000).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"